Spectral AI Inc. Class A Common Stock Q3 2025 Earnings Recap

MDAI Q3 2025 November 12, 2025

Get alerts when MDAI reports next quarter

Spectral AI Inc. reported disappointing financial results for Q3 2025, including reduced research revenues and a widened net loss, while maintaining a stable cash position to support ongoing development.

Earnings Per Share Miss

$-0.13 vs $-0.09 est.

-52.9% surprise

Revenue Miss

3792000 vs 5062500 est.

-25.1% surprise

Market Reaction

1-Day -6.98%

5-Day -16.28%

30-Day -4.07%

See MDAI alongside your other holdings

Add to your portfolio — free

Key Takeaways

R&D revenue dropped to $3.8 million from $8.2 million year-over-year due to reduced BARDA reimbursements.
Net loss increased to $3.6 million, compared to a $1.5 million loss in Q3 2024, driven by higher administrative costs.
Cash and cash equivalents remained steady at $10.5 million, bolstered by a recent $7.6 million equity offering.
FDA submission for the DeepView system marks a crucial milestone for the company's growth strategy, despite slower interactions due to government delays.
General and administrative expenses rose to $5 million, reflecting increased consulting costs and non-billable work.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit MDAI on AllInvestView.

Previous Q2 2025